Concepedia

Malcolm J. Sheardown

MJ

60

Publications

4.8K

Citations

34

H-Index

1981

Active since

Affiliations

Novo Nordisk (Denmark)(Current)

Eli Lilly (United States)

Ferrosan Medical Devices (Denmark)

University of Copenhagen

St Thomas' Hospital

Malcolm J. Sheardown is an author at Novo Nordisk (Denmark) specializing in medicine, neuropharmacology, and pharmacology.

Top concepts

Publications per year

1981–2009

60

Publications

60

2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a Neuroprotectant for Cerebral Ischemia

Malcolm J. Sheardown, Elsebet Ø. Nielsen, Anker Jón Hansen et al. · Science · 1990 · 1.1K citations

, , +18

Functional characterization of agonists at recombinant human 5‐HT<sub>2A</sub>, 5‐HT<sub>2B</sub> and 5‐HT<sub>2C</sub> receptors in CHO‐K1 cells

Richard H. Porter, Karen Benwell, Helen Lamb et al. · British Journal of Pharmacology · 1999 · 354 citations · Full text

Regional Changes in Interstitial K<sup>+</sup> and Ca<sup>2+</sup> Levels following Cortical Compression Contusion Trauma in Rats

Pelle Nilsson, Lars Hillered, Yngve Olsson et al. · Journal of Cerebral Blood Flow & Metabolism · 1993 · 275 citations · Full text

AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24 h

Malcolm J. Sheardown, Peter D. Suzdak, Lars Nordholm · European Journal of Pharmacology · 1993 · 192 citations

, , +12

ZK200775: A phosphonate quinoxalinedione AMPA antagonist for neuroprotection in stroke and trauma

Lechosław Turski, Andreas Huth, Malcolm J. Sheardown et al. · Proceedings of the National Academy of Sciences · 1998 · 167 citations · Full text

, , +27

Rows per page

1–5 of 60